⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplemental Table S1 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper Rye J. Anderson Ed Baker Tiffany M. Yu

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for the model inputs

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Harper et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db6435875232cd https://doi.org/10.1158/1940-6207.27026963

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table S1 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
2Supplemental Table S2 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
3Supplemental Table S2 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
4Supplemental Table S4 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
5Supplemental Table S4 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024